speb/financial-data huggingface dataset:
CDLX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -189304000.00
CDLX cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
CDLX income_statement (annual, 2024-12-31) — Net Interest Income: -5553000.00
CDLX cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -26803000.00
CDLX cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -26803000.00
CDLX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -5553000.00
CDLX cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -20398000.00
CDLX balance_sheet (annual, 2024-12-31) — Net PPE: 8937000.00
CDLX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -1562000.00
CDLX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -134149000.00
CDLX balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 0.00
CDLX balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 0.00
CDLX balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 0.00
CDLX balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 0.00
CDLX income_statement (annual, 2024-12-31) — Normalized EBITDA: -32307000.00
CDLX income_statement (annual, 2024-12-31) — Normalized Income: -69086000.00
CDLX cash_flow (annual, 2024-12-31) — Operating Cash Flow: -8824000.00
CDLX cash_flow (annual, 2024-12-31) — Operating Gains Losses: -13017000.00
CDLX income_statement (annual, 2024-12-31) — Operating Income: -63533000.00
CDLX income_statement (annual, 2024-12-31) — Operating Revenue: 278298000.00
CDLX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 5125700.00
CDLX balance_sheet (annual, 2024-12-31) — Other Current Assets: 5336000.00
CDLX balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 45863000.00
CDLX balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 45863000.00
CDLX balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 4563000.00
CDLX balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 4563000.00
CDLX balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 3601000.00
CDLX income_statement (annual, 2024-12-31) — Other Gand A: 43769000.00
CDLX income_statement (annual, 2024-12-31) — Other Income Expense: -120218000.00
CDLX balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 44713000.00
CDLX cash_flow (annual, 2024-12-31) — Other Non Cash Items: 9430000.00
CDLX balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1650000.00
CDLX balance_sheet (annual, 2024-12-31) — Other Properties: 6341000.00
CDLX balance_sheet (annual, 2024-12-31) — Other Receivables: 3801000.00
CDLX income_statement (annual, 2024-12-31) — Other Special Charges: -13017000.00
CDLX income_statement (quarterly, 2024-12-31) — Other Special Charges: 0.00
CDLX balance_sheet (annual, 2024-12-31) — Payables: 36168000.00
CDLX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 88856000.00
CDLX balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 5494000.00
CDLX income_statement (annual, 2024-12-31) — Pretax Income: -189304000.00
CDLX balance_sheet (annual, 2024-12-31) — Properties: 0.00
CDLX balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CDLX cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
CDLX cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: 0.00
CDLX cash_flow (annual, 2024-12-31) — Purchase Of PPE: -1562000.00
CDLX balance_sheet (annual, 2024-12-31) — Receivables: 107053000.00
CDLX income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 155217000.00
CDLX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 27876000.00
CDLX cash_flow (annual, 2024-12-31) — Repayment Of Debt: -199303000.00
CDLX cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
CDLX income_statement (annual, 2024-12-31) — Research And Development: 49607000.00
CDLX income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 371000.00
CDLX balance_sheet (annual, 2024-12-31) — Retained Earnings: -1300576000.00
CDLX income_statement (annual, 2024-12-31) — Salaries And Wages: 22730000.00
CDLX cash_flow (annual, 2024-12-31) — Sale Of Business: 552000.00
CDLX income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 42632000.00
CDLX income_statement (annual, 2024-12-31) — Selling General And Administration: 109131000.00
CDLX balance_sheet (annual, 2024-12-31) — Share Issued: 5125700.00
CDLX income_statement (annual, 2024-12-31) — Special Income Charges: -118949000.00
CDLX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 40367000.00
CDLX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 69993000.00
CDLX balance_sheet (annual, 2024-12-31) — Tangible Book Value: -134149000.00
CDLX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CDLX income_statement (annual, 2024-12-31) — Tax Provision: 0.00
CDLX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
CDLX balance_sheet (annual, 2024-12-31) — Total Assets: 392711000.00
CDLX balance_sheet (annual, 2024-12-31) — Total Capitalization: 237722000.00
CDLX balance_sheet (annual, 2024-12-31) — Total Debt: 221651000.00
CDLX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 69993000.00
CDLX income_statement (annual, 2024-12-31) — Total Expenses: 341831000.00
CDLX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 322718000.00
CDLX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 214729000.00
CDLX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 173763000.00
CDLX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -195499000.00
CDLX income_statement (annual, 2024-12-31) — Total Unusual Items: -120218000.00
CDLX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -120218000.00
CDLX balance_sheet (annual, 2024-12-31) — Working Capital: 29028000.00
CDLX income_statement (quarterly, 2025-03-31) — +Operating Expense: 37950000.00
CDLX income_statement (quarterly, 2025-03-31) — +Total Revenue: 56435000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 4445000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 96094000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1376692000.00
CDLX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 5186300.00
CDLX income_statement (quarterly, 2025-03-31) — Basic EPS: -2.60
CDLX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 65594000.00
CDLX cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -4103000.00
CDLX cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -3984000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 6781000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 10000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 52046000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 52046000.00
CDLX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -3034000.00
CDLX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -3903000.00
CDLX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -6706000.00
CDLX cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 551000.00
CDLX cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 1895000.00
CDLX cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -12105000.00
CDLX cash_flow (quarterly, 2025-03-31) — Change In Payable: 551000.00
CDLX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 2446000.00
CDLX cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -56000.00
CDLX cash_flow (quarterly, 2025-03-31) — Change In Receivables: 7536000.00
CDLX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -2179000.00
CDLX cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 7536000.00
CDLX cash_flow (quarterly, 2025-03-31) — Changes In Cash: -13643000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Common Stock: 10000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 64090000.00
CDLX cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
CDLX income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 34890000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 40178000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Current Assets: 156829000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 1658000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Current Debt: 45936000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 47594000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 2608000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 2608000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 131851000.00
CDLX cash_flow (quarterly, 2025-03-31) — Depreciation: 6923000.00
CDLX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 6923000.00
CDLX income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 4347000.00
CDLX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 6923000.00
CDLX income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 4347000.00
CDLX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 5186300.00
CDLX income_statement (quarterly, 2025-03-31) — Diluted EPS: -2.60
CDLX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -13282000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 28759000.00
CDLX income_statement (quarterly, 2025-03-31) — EBIT: -7942000.00
CDLX income_statement (quarterly, 2025-03-31) — EBITDA: -1019000.00
CDLX cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 95000.00
CDLX cash_flow (quarterly, 2025-03-31) — End Cash Position: 52046000.00
CDLX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -3034000.00
CDLX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -10809000.00
CDLX cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of Business: -5350000.00
CDLX income_statement (quarterly, 2025-03-31) — Gain On Sale Of Business: 5350000.00
CDLX income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 2627000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 1246000.00
CDLX income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 12943000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Goodwill: 159429000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 203212000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 7528000.00
CDLX income_statement (quarterly, 2025-03-31) — Gross Profit: 21545000.00
CDLX income_statement (quarterly, 2025-03-31) — Interest Expense: 2376000.00
CDLX income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 2376000.00
CDLX income_statement (quarterly, 2025-03-31) — Interest Income: 546000.00
CDLX income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 546000.00
CDLX cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 253000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 278035000.00
CDLX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -3903000.00
CDLX cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
CDLX cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
CDLX balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 5123000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 168009000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 173132000.00
CDLX cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
CDLX cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: 0.00
CDLX cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 200000.00
CDLX cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
CDLX balance_sheet (quarterly, 2025-03-31) — Net Debt: 161899000.00
CDLX income_statement (quarterly, 2025-03-31) — Net Income: -13282000.00
CDLX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -13282000.00
CDLX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -10318000.00
CDLX income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: -2964000.00
CDLX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -13282000.00
CDLX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -10318000.00
CDLX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -13282000.00
CDLX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -13282000.00
CDLX income_statement (quarterly, 2025-03-31) — Net Interest Income: -1830000.00
CDLX cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
CDLX cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 0.00
CDLX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -1830000.00
CDLX cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -3034000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Net PPE: 7528000.00
CDLX cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -119000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -139122000.00
CDLX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -8936000.00
CDLX income_statement (quarterly, 2025-03-31) — Normalized Income: -18235000.00
CDLX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -6706000.00
CDLX cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -5350000.00
CDLX income_statement (quarterly, 2025-03-31) — Operating Income: -16405000.00
CDLX income_statement (quarterly, 2025-03-31) — Operating Revenue: 56435000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 5217500.00
CDLX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 5331000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 45936000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 1825000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 1246000.00
CDLX income_statement (quarterly, 2025-03-31) — Other Gand A: 12943000.00
CDLX income_statement (quarterly, 2025-03-31) — Other Income Expense: 7917000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 43783000.00
CDLX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -1512000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1504000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Other Properties: 7528000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Other Receivables: 3358000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Payables: 33204000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 73382000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 6442000.00
CDLX income_statement (quarterly, 2025-03-31) — Pretax Income: -10318000.00
CDLX cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -119000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Receivables: 99452000.00
CDLX income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 32314000.00
CDLX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 6923000.00
CDLX cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: 0.00
CDLX income_statement (quarterly, 2025-03-31) — Research And Development: 10278000.00
CDLX income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 60000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1313858000.00
CDLX cash_flow (quarterly, 2025-03-31) — Sale Of Business: 200000.00
CDLX income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 10382000.00
CDLX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 23325000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Share Issued: 5217500.00
CDLX income_statement (quarterly, 2025-03-31) — Special Income Charges: 5290000.00
CDLX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 8694000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 64090000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -139122000.00
CDLX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CDLX income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
CDLX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
CDLX balance_sheet (quarterly, 2025-03-31) — Total Assets: 369073000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 232099000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Total Debt: 220726000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 64090000.00
CDLX income_statement (quarterly, 2025-03-31) — Total Expenses: 72840000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 304983000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 212244000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 173132000.00
CDLX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -11115000.00
CDLX income_statement (quarterly, 2025-03-31) — Total Unusual Items: 7917000.00
CDLX income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 7917000.00
CDLX balance_sheet (quarterly, 2025-03-31) — Working Capital: 24978000.00
CDLX income_statement (quarterly, 2025-06-30) — +Operating Expense: 41810000.00
CDLX income_statement (quarterly, 2025-06-30) — +Total Revenue: 63249000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1945000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 93189000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1385465000.00
CDLX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 5275000.00
CDLX income_statement (quarterly, 2025-06-30) — Basic EPS: -1.80
CDLX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 52046000.00
CDLX cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -4658000.00
CDLX cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -4336000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 6114000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 10000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 46745000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 46745000.00
CDLX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -2059000.00
CDLX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -4658000.00
CDLX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 1225000.00
CDLX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -2388000.00
CDLX cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -975000.00
CDLX cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 2018000.00
CDLX cash_flow (quarterly, 2025-06-30) — Change In Payable: -2388000.00
CDLX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -3363000.00
CDLX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -1569000.00
CDLX cash_flow (quarterly, 2025-06-30) — Change In Receivables: 2629000.00
CDLX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -285000.00
CDLX cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 2629000.00
CDLX cash_flow (quarterly, 2025-06-30) — Changes In Cash: -5492000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Common Stock: 10000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 58706000.00
CDLX cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
CDLX income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 33986000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 42453000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Current Assets: 150400000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 1199000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Current Debt: 46009000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 47208000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 3103000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 3103000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 129149000.00
CDLX cash_flow (quarterly, 2025-06-30) — Depreciation: 6917000.00
CDLX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 6917000.00
CDLX income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 6275000.00
CDLX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 6917000.00
CDLX income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 6275000.00
CDLX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 5275000.00
CDLX income_statement (quarterly, 2025-06-30) — Diluted EPS: -1.80
CDLX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -9283000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 27196000.00
CDLX income_statement (quarterly, 2025-06-30) — EBIT: -6914000.00
CDLX income_statement (quarterly, 2025-06-30) — EBITDA: 3000.00
CDLX cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 191000.00
CDLX cash_flow (quarterly, 2025-06-30) — End Cash Position: 46745000.00
CDLX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -2059000.00
CDLX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -3433000.00
CDLX cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of Business: 200000.00
CDLX income_statement (quarterly, 2025-06-30) — Gain On Sale Of Business: -200000.00
CDLX income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 5449000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -3628000.00
CDLX income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 12905000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Goodwill: 159429000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 202306000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 7022000.00
CDLX income_statement (quarterly, 2025-06-30) — Gross Profit: 29263000.00
CDLX income_statement (quarterly, 2025-06-30) — Interest Expense: 2369000.00
CDLX income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 2369000.00
CDLX income_statement (quarterly, 2025-06-30) — Interest Income: 426000.00
CDLX income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 426000.00
CDLX cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 3688000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 273004000.00
CDLX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -4658000.00
CDLX cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
CDLX cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
CDLX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 4915000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 168289000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 173204000.00
CDLX cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
CDLX cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: 0.00
CDLX cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
CDLX cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
CDLX balance_sheet (quarterly, 2025-06-30) — Net Debt: 167553000.00
CDLX income_statement (quarterly, 2025-06-30) — Net Income: -9283000.00
CDLX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -9283000.00
CDLX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -9283000.00
CDLX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -9283000.00
CDLX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -9283000.00
CDLX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -9283000.00
CDLX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -9283000.00
CDLX income_statement (quarterly, 2025-06-30) — Net Interest Income: -1943000.00
CDLX cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 0.00
CDLX cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 0.00
CDLX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -1943000.00
CDLX cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -2059000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Net PPE: 7022000.00
CDLX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -322000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -143600000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 75000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 75000.00
CDLX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -5204000.00
CDLX income_statement (quarterly, 2025-06-30) — Normalized Income: -14490000.00
CDLX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 1225000.00
CDLX cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 200000.00
CDLX income_statement (quarterly, 2025-06-30) — Operating Income: -12547000.00
CDLX income_statement (quarterly, 2025-06-30) — Operating Revenue: 63249000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 5299400.00
CDLX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 7035000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 46009000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -3628000.00
CDLX income_statement (quarterly, 2025-06-30) — Other Gand A: 12905000.00
CDLX income_statement (quarterly, 2025-06-30) — Other Income Expense: 5207000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 42877000.00
CDLX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -3825000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 1406000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Other Properties: 7022000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Other Receivables: 3431000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Payables: 29141000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 71594000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 7244000.00
CDLX income_statement (quarterly, 2025-06-30) — Pretax Income: -9283000.00
CDLX cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -322000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Receivables: 96620000.00
CDLX income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 33344000.00
CDLX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 6917000.00
CDLX cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: 0.00
CDLX income_statement (quarterly, 2025-06-30) — Research And Development: 11295000.00
CDLX income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 42000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1323141000.00
CDLX cash_flow (quarterly, 2025-06-30) — Sale Of Business: 0.00
CDLX income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 11335000.00
CDLX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 24240000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Share Issued: 5299400.00
CDLX income_statement (quarterly, 2025-06-30) — Special Income Charges: -242000.00
CDLX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 7501000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 58706000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -143600000.00
CDLX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CDLX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
CDLX balance_sheet (quarterly, 2025-06-30) — Total Assets: 361134000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 226995000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Total Debt: 220412000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 58706000.00
CDLX income_statement (quarterly, 2025-06-30) — Total Expenses: 75796000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 302428000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 210734000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 173279000.00
CDLX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -12789000.00
CDLX income_statement (quarterly, 2025-06-30) — Total Unusual Items: 5207000.00
CDLX income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 5207000.00
CDLX balance_sheet (quarterly, 2025-06-30) — Working Capital: 21251000.00
CDLX income_statement (quarterly, 2025-09-30) — +Operating Expense: 33991000.00
CDLX income_statement (quarterly, 2025-09-30) — +Total Revenue: 52031000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 3613000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 85496000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1393138000.00
CDLX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 5349300.00
CDLX income_statement (quarterly, 2025-09-30) — Basic EPS: -13.60
CDLX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 46745000.00
CDLX cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -4464000.00
CDLX cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -4450000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 6793000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 10000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 43961000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 43961000.00
CDLX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -12000.00
CDLX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -4464000.00
CDLX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 1761000.00
CDLX cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 1644000.00
CDLX cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 842000.00
CDLX cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -8826000.00
CDLX cash_flow (quarterly, 2025-09-30) — Change In Payable: 1644000.00
CDLX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 2486000.00
CDLX cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 1395000.00
CDLX cash_flow (quarterly, 2025-09-30) — Change In Receivables: 4643000.00
CDLX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -302000.00
CDLX cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 4643000.00
CDLX cash_flow (quarterly, 2025-09-30) — Changes In Cash: -2715000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Common Stock: 10000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -4704000.00
CDLX cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
CDLX income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 27731000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 39583000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Current Assets: 140710000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1617000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Current Debt: 46070000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 47687000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 3372000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 3372000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 123703000.00
CDLX cash_flow (quarterly, 2025-09-30) — Depreciation: 6988000.00
CDLX cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 6988000.00
CDLX income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 6473000.00
CDLX cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 6988000.00
CDLX income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 6473000.00
CDLX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 5349300.00
CDLX income_statement (quarterly, 2025-09-30) — Diluted EPS: -13.60
CDLX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -72673000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 22153000.00
CDLX income_statement (quarterly, 2025-09-30) — EBIT: -69758000.00
CDLX income_statement (quarterly, 2025-09-30) — EBITDA: -62770000.00
CDLX cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -69000.00
CDLX cash_flow (quarterly, 2025-09-30) — End Cash Position: 43961000.00
CDLX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -12000.00
CDLX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -2703000.00
CDLX cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of Business: 319000.00
CDLX income_statement (quarterly, 2025-09-30) — Gain On Sale Of Business: -320000.00
CDLX income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -1812000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -2038000.00
CDLX income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 10854000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Goodwill: 110305000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 142907000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 7534000.00
CDLX income_statement (quarterly, 2025-09-30) — Gross Profit: 24300000.00
CDLX income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 58843000.00
CDLX income_statement (quarterly, 2025-09-30) — Interest Expense: 2915000.00
CDLX income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 2915000.00
CDLX income_statement (quarterly, 2025-09-30) — Interest Income: 908000.00
CDLX income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 908000.00
CDLX cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 839000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 209936000.00
CDLX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -4464000.00
CDLX cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
CDLX cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 50000000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 46070000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 5176000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 168570000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 173746000.00
CDLX cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 50000000.00
CDLX cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -50000000.00
CDLX cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
CDLX cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CDLX balance_sheet (quarterly, 2025-09-30) — Net Debt: 170679000.00
CDLX income_statement (quarterly, 2025-09-30) — Net Income: -72673000.00
CDLX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -72673000.00
CDLX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -72673000.00
CDLX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -72673000.00
CDLX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -72673000.00
CDLX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -72673000.00
CDLX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -72673000.00
CDLX income_statement (quarterly, 2025-09-30) — Net Interest Income: -2007000.00
CDLX cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
CDLX cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
CDLX income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -2007000.00
CDLX cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -12000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Net PPE: 7534000.00
CDLX cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -14000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -147611000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 62000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 62000.00
CDLX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -1795000.00
CDLX income_statement (quarterly, 2025-09-30) — Normalized Income: -11698000.00
CDLX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 1761000.00
CDLX cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 319000.00
CDLX income_statement (quarterly, 2025-09-30) — Operating Income: -9691000.00
CDLX income_statement (quarterly, 2025-09-30) — Operating Revenue: 52031000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 5380600.00
CDLX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 5345000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -2038000.00
CDLX income_statement (quarterly, 2025-09-30) — Other Gand A: 10854000.00
CDLX income_statement (quarterly, 2025-09-30) — Other Income Expense: -60975000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 32602000.00
CDLX cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 2164000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 1656000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Other Properties: 7534000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Other Receivables: 5908000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Payables: 25766000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 65349000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 7295000.00
CDLX income_statement (quarterly, 2025-09-30) — Pretax Income: -72673000.00
CDLX cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -14000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Receivables: 91404000.00
CDLX income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 27216000.00
CDLX income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 6988000.00
CDLX cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -50000000.00
CDLX income_statement (quarterly, 2025-09-30) — Research And Development: 8799000.00
CDLX income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 0.00
CDLX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1395814000.00
CDLX cash_flow (quarterly, 2025-09-30) — Sale Of Business: 0.00
CDLX income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 7865000.00
CDLX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 18719000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Share Issued: 5380600.00
CDLX income_statement (quarterly, 2025-09-30) — Special Income Charges: -59163000.00
CDLX cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 6422000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -4704000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -147611000.00
CDLX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CDLX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
CDLX balance_sheet (quarterly, 2025-09-30) — Total Assets: 292807000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 163866000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Total Debt: 221433000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -4704000.00
CDLX income_statement (quarterly, 2025-09-30) — Total Expenses: 61722000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 297511000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 152097000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 173808000.00
CDLX income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -68854000.00
CDLX income_statement (quarterly, 2025-09-30) — Total Unusual Items: -60975000.00
CDLX income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -60975000.00
CDLX balance_sheet (quarterly, 2025-09-30) — Working Capital: 17007000.00
CDLX income_statement (annual, 2025-12-31) — +Operating Expense: 150318000.00
CDLX income_statement (quarterly, 2025-12-31) — +Operating Expense: 29988000.00
CDLX income_statement (annual, 2025-12-31) — +Total Revenue: 233273000.00
CDLX income_statement (quarterly, 2025-12-31) — +Total Revenue: 56095000.00
CDLX balance_sheet (annual, 2025-12-31) — Accounts Payable: 3360000.00
CDLX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 3360000.00
CDLX balance_sheet (annual, 2025-12-31) — Accounts Receivable: 82669000.00
CDLX balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 82669000.00
CDLX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -4737000.00
CDLX balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -4737000.00
CDLX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1399542000.00
CDLX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1399542000.00
CDLX balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -4047000.00
CDLX balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -4047000.00
CDLX cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 58843000.00
CDLX cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
CDLX income_statement (annual, 2025-12-31) — Basic Average Shares: 5311400.00
CDLX income_statement (quarterly, 2025-12-31) — Basic Average Shares: 5431800.00
CDLX income_statement (annual, 2025-12-31) — Basic EPS: -19.50
CDLX income_statement (quarterly, 2025-12-31) — Basic EPS: -1.50
CDLX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 65594000.00
CDLX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 43961000.00
CDLX cash_flow (annual, 2025-12-31) — Capital Expenditure: -15782000.00
CDLX cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -2557000.00
CDLX cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -15302000.00
CDLX cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -2532000.00
CDLX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 6394000.00
CDLX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 6394000.00
CDLX balance_sheet (annual, 2025-12-31) — Capital Stock: 10000.00
CDLX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 10000.00
CDLX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 48719000.00
CDLX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 48719000.00
CDLX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 48719000.00
CDLX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 48719000.00
CDLX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -11122000.00
CDLX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -6017000.00
CDLX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -15302000.00
CDLX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -2277000.00
CDLX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 9290000.00
CDLX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 13010000.00
CDLX cash_flow (annual, 2025-12-31) — Change In Account Payable: 179000.00
CDLX cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 372000.00
CDLX cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -724000.00
CDLX cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -2486000.00
CDLX cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -16188000.00
CDLX cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 2725000.00
CDLX cash_flow (annual, 2025-12-31) — Change In Payable: 179000.00
CDLX cash_flow (quarterly, 2025-12-31) — Change In Payable: 372000.00
CDLX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -545000.00
CDLX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -2114000.00
CDLX cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 1803000.00
CDLX cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 2033000.00
CDLX cash_flow (annual, 2025-12-31) — Change In Receivables: 20643000.00
CDLX cash_flow (quarterly, 2025-12-31) — Change In Receivables: 5835000.00
CDLX cash_flow (annual, 2025-12-31) — Change In Working Capital: 5713000.00
CDLX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 8479000.00
CDLX cash_flow (annual, 2025-12-31) — Changes In Cash: -17134000.00
CDLX cash_flow (quarterly, 2025-12-31) — Changes In Cash: 4716000.00
CDLX balance_sheet (annual, 2025-12-31) — Common Stock: 10000.00
CDLX balance_sheet (quarterly, 2025-12-31) — Common Stock: 10000.00
CDLX balance_sheet (annual, 2025-12-31) — Common Stock Equity: -6508000.00
CDLX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -6508000.00
CDLX cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
CDLX cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
CDLX income_statement (annual, 2025-12-31) — Cost Of Revenue: 128660000.00
CDLX income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 30205000.00
CDLX balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 39869000.00
CDLX balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 39869000.00
CDLX balance_sheet (annual, 2025-12-31) — Current Assets: 137279000.00
CDLX balance_sheet (quarterly, 2025-12-31) — Current Assets: 137279000.00
CDLX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1607000.00
CDLX balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1607000.00
CDLX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1607000.00
CDLX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1607000.00
CDLX balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 2589000.00
CDLX balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 2589000.00
CDLX balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 2589000.00
CDLX balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 2589000.00
CDLX balance_sheet (annual, 2025-12-31) — Current Liabilities: 78390000.00